IRIS for Good Pharmacovigilance practice (GVP) inspections training session for industry users
Event
Human
Pharmacovigilance
Date
Location
|
Update: EMA has rescheduled this event from 8 September 2022 to 7 September 2022. |
Good Pharmacovigilance practice (GVP) inspections are conducted to ensure that requirements for monitoring the safety of medicines are met. The responsibility for carrying out the inspections rests with the national competent authorities.
The European Medicines Agency (EMA) coordinates GVP inspections requested by the Committee for Medicinal Products for Human Use (CHMP) and the Committee for Medicinal Products for Veterinary Use (CVMP).
Following the go-live of IRIS for Good Manufacturing Practice (GMP) and Good Clinical Practice (GCP) inspections, EMA is onboarding GVP Inspections on the IRIS platform with an expected go-live in Q3 2022.
The benefits relevant to industry stakeholders include:
This webinar aims to explain the GVP Inspections business process in IRIS highlighting the changes and answer any potential questions from industry users.
Topics that will be addressed in this webinar include: